JP2009536660A - 加水分解耐性ホウ素含有治療剤及びその使用方法 - Google Patents

Info

Publication number

JP2009536660A

JP2009536660A JP2009510064A JP2009510064A JP2009536660A JP 2009536660 A JP2009536660 A JP 2009536660A JP 2009510064 A JP2009510064 A JP 2009510064A JP 2009510064 A JP2009510064 A JP 2009510064A JP 2009536660 A JP2009536660 A JP 2009536660A

Authority

JP

Japan

Prior art keywords

substituted

unsubstituted

alkyl

compound

member selected

Prior art date

2006-05-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 82
• 229910052796 boron Inorganic materials 0.000 title claims description 9
• ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 title claims description 6
• 239000003814 drug Substances 0.000 title abstract description 51
• 229940124597 therapeutic agent Drugs 0.000 title abstract description 6
• 230000007062 hydrolysis Effects 0.000 title 1
• 238000006460 hydrolysis reaction Methods 0.000 title 1
• 239000000203 mixture Substances 0.000 claims abstract description 126
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 26
• 201000010099 disease Diseases 0.000 claims abstract description 23
• 241000233866 Fungi Species 0.000 claims abstract description 19
• 241000700605 Viruses Species 0.000 claims abstract description 19
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 14
• 230000002194 synthesizing effect Effects 0.000 claims abstract description 4
• 150000001875 compounds Chemical class 0.000 claims description 280
• -1 CF 3 Inorganic materials 0.000 claims description 83
• 125000000217 alkyl group Chemical group 0.000 claims description 57
• 229910052739 hydrogen Inorganic materials 0.000 claims description 46
• 125000003118 aryl group Chemical group 0.000 claims description 40
• 208000015181 infectious disease Diseases 0.000 claims description 30
• 150000003839 salts Chemical class 0.000 claims description 25
• 241001465754 Metazoa Species 0.000 claims description 24
• 125000001072 heteroaryl group Chemical group 0.000 claims description 22
• 125000003710 aryl alkyl group Chemical group 0.000 claims description 20
• 229910052736 halogen Inorganic materials 0.000 claims description 18
• 150000002367 halogens Chemical class 0.000 claims description 16
• 244000005700 microbiome Species 0.000 claims description 14
• 125000004404 heteroalkyl group Chemical group 0.000 claims description 13
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
• 230000002401 inhibitory effect Effects 0.000 claims description 12
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
• 229910002091 carbon monoxide Inorganic materials 0.000 claims description 9
• 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 9
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 9
• 230000012010 growth Effects 0.000 claims description 9
• 229910052760 oxygen Inorganic materials 0.000 claims description 9
• 229910052717 sulfur Inorganic materials 0.000 claims description 9
• 125000003545 alkoxy group Chemical group 0.000 claims description 8
• 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 8
• 239000001257 hydrogen Substances 0.000 claims description 8
• 125000004104 aryloxy group Chemical group 0.000 claims description 7
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 6
• 229920002554 vinyl polymer Polymers 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 5
• 125000004288 oxazolidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC1([H])* 0.000 claims description 4
• 230000002147 killing effect Effects 0.000 claims description 3
• 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
• 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 2
• 230000003612 virological effect Effects 0.000 claims description 2
• 125000001589 carboacyl group Chemical group 0.000 claims 3
• 150000002431 hydrogen Chemical class 0.000 claims 1
• 238000011282 treatment Methods 0.000 abstract description 31
• 241000894006 Bacteria Species 0.000 abstract description 12
• QGBXFSMYOZRUBS-UHFFFAOYSA-N 1,2-benzothiaborole Chemical compound C1=CC=C2SB=CC2=C1 QGBXFSMYOZRUBS-UHFFFAOYSA-N 0.000 abstract description 2
• YLCSRFRHQWMMGV-UHFFFAOYSA-N 1h-1,2-benzazaborole Chemical compound C1=CC=C2NB=CC2=C1 YLCSRFRHQWMMGV-UHFFFAOYSA-N 0.000 abstract description 2
• 150000001638 boron Chemical class 0.000 abstract 1
• 210000000282 nail Anatomy 0.000 description 107
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 68
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
• 239000002904 solvent Substances 0.000 description 57
• 238000005481 NMR spectroscopy Methods 0.000 description 55
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 48
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 48
• 229940079593 drug Drugs 0.000 description 44
• 210000003491 skin Anatomy 0.000 description 39
• 239000000243 solution Substances 0.000 description 39
• 238000009472 formulation Methods 0.000 description 38
• 210000000003 hoof Anatomy 0.000 description 34
• 230000002829 reductive effect Effects 0.000 description 34
• 238000004128 high performance liquid chromatography Methods 0.000 description 32
• 210000004209 hair Anatomy 0.000 description 31
• 239000003795 chemical substances by application Substances 0.000 description 30
• 210000004027 cell Anatomy 0.000 description 29
• 239000008194 pharmaceutical composition Substances 0.000 description 29
• 229910052799 carbon Inorganic materials 0.000 description 28
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 28
• 210000000078 claw Anatomy 0.000 description 27
• 230000000694 effects Effects 0.000 description 26
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 25
• 239000013543 active substance Substances 0.000 description 25
• 235000019441 ethanol Nutrition 0.000 description 25
• 239000012049 topical pharmaceutical composition Substances 0.000 description 24
• 235000019439 ethyl acetate Nutrition 0.000 description 23
• 125000001424 substituent group Chemical group 0.000 description 23
• 208000010195 Onychomycosis Diseases 0.000 description 21
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
• 239000012267 brine Substances 0.000 description 21
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 21
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 20
• 239000000126 substance Substances 0.000 description 20
• 201000005882 tinea unguium Diseases 0.000 description 20
• 239000000463 material Substances 0.000 description 19
• 239000012074 organic phase Substances 0.000 description 19
• 230000000699 topical effect Effects 0.000 description 19
• 230000035515 penetration Effects 0.000 description 18
• 239000007787 solid Substances 0.000 description 17
• 241000282414 Homo sapiens Species 0.000 description 16
• 229940121375 antifungal agent Drugs 0.000 description 16
• 239000003995 emulsifying agent Substances 0.000 description 16
• 239000003755 preservative agent Substances 0.000 description 16
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
• 239000004480 active ingredient Substances 0.000 description 15
• 238000003556 assay Methods 0.000 description 15
• 229910052757 nitrogen Inorganic materials 0.000 description 15
• 239000003921 oil Substances 0.000 description 15
• BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 14
• 238000012360 testing method Methods 0.000 description 14
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 13
• 239000000460 chlorine Substances 0.000 description 13
• 239000003974 emollient agent Substances 0.000 description 13
• 239000002609 medium Substances 0.000 description 13
• 239000011734 sodium Substances 0.000 description 13
• 241000894007 species Species 0.000 description 13
• 239000003981 vehicle Substances 0.000 description 13
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
• 235000019198 oils Nutrition 0.000 description 12
• 239000000546 pharmaceutical excipient Substances 0.000 description 12
• 241000222722 Leishmania <genus> Species 0.000 description 11
• 125000005842 heteroatom Chemical group 0.000 description 11
• 239000007788 liquid Substances 0.000 description 11
• GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 11
• 239000006071 cream Substances 0.000 description 10
• 239000000839 emulsion Substances 0.000 description 10
• 238000012986 modification Methods 0.000 description 10
• 230000004048 modification Effects 0.000 description 10
• 231100000252 nontoxic Toxicity 0.000 description 10
• 230000003000 nontoxic effect Effects 0.000 description 10
• WWEZFHIIGHABQR-UHFFFAOYSA-N 1-bromo-4-chloro-2-(methoxymethoxymethyl)benzene Chemical compound COCOCC1=CC(Cl)=CC=C1Br WWEZFHIIGHABQR-UHFFFAOYSA-N 0.000 description 9
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
• 206010061304 Nail infection Diseases 0.000 description 9
• 241000223229 Trichophyton rubrum Species 0.000 description 9
• 239000003963 antioxidant agent Substances 0.000 description 9
• 235000006708 antioxidants Nutrition 0.000 description 9
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 9
• 239000003883 ointment base Substances 0.000 description 9
• 229920001451 polypropylene glycol Polymers 0.000 description 9
• 150000003254 radicals Chemical class 0.000 description 9
• 230000001225 therapeutic effect Effects 0.000 description 9
• 239000002562 thickening agent Substances 0.000 description 9
• 241001480043 Arthrodermataceae Species 0.000 description 8
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
• 206010017533 Fungal infection Diseases 0.000 description 8
• 108060001084 Luciferase Proteins 0.000 description 8
• 239000005089 Luciferase Substances 0.000 description 8
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
• 241001045770 Trichophyton mentagrophytes Species 0.000 description 8
• 230000000843 anti-fungal effect Effects 0.000 description 8
• 239000003429 antifungal agent Substances 0.000 description 8
• 230000001580 bacterial effect Effects 0.000 description 8
• 125000004432 carbon atom Chemical group C* 0.000 description 8
• 238000004113 cell culture Methods 0.000 description 8
• 239000012230 colorless oil Substances 0.000 description 8
• 239000002537 cosmetic Substances 0.000 description 8
• 230000037304 dermatophytes Effects 0.000 description 8
• 239000003623 enhancer Substances 0.000 description 8
• 150000002148 esters Chemical class 0.000 description 8
• 210000004904 fingernail bed Anatomy 0.000 description 8
• 230000002335 preservative effect Effects 0.000 description 8
• 230000009885 systemic effect Effects 0.000 description 8
• 241000282412 Homo Species 0.000 description 7
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
• 239000002253 acid Substances 0.000 description 7
• 125000002947 alkylene group Chemical group 0.000 description 7
• 238000004458 analytical method Methods 0.000 description 7
• 230000003078 antioxidant effect Effects 0.000 description 7
• 125000004429 atom Chemical group 0.000 description 7
• 229960000541 cetyl alcohol Drugs 0.000 description 7
• XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 7
• 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 7
• 239000000796 flavoring agent Substances 0.000 description 7
• 239000000499 gel Substances 0.000 description 7
• 239000006210 lotion Substances 0.000 description 7
• 238000002844 melting Methods 0.000 description 7
• 230000008018 melting Effects 0.000 description 7
• 239000012299 nitrogen atmosphere Substances 0.000 description 7
• 244000045947 parasite Species 0.000 description 7
• 238000002360 preparation method Methods 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 238000000746 purification Methods 0.000 description 7
• 238000010898 silica gel chromatography Methods 0.000 description 7
• 210000000434 stratum corneum Anatomy 0.000 description 7
• 239000000725 suspension Substances 0.000 description 7
• 210000001519 tissue Anatomy 0.000 description 7
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
• 241000283690 Bos taurus Species 0.000 description 6
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
• 241000222122 Candida albicans Species 0.000 description 6
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
• 241000221204 Cryptococcus neoformans Species 0.000 description 6
• 208000031888 Mycoses Diseases 0.000 description 6
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
• OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
• 230000000840 anti-viral effect Effects 0.000 description 6
• 239000000969 carrier Substances 0.000 description 6
• 239000002738 chelating agent Substances 0.000 description 6
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
• 238000000338 in vitro Methods 0.000 description 6
• 239000003112 inhibitor Substances 0.000 description 6
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
• OHENQANLQNOMAO-UHFFFAOYSA-N oxaborole Chemical group O1B=CC=C1 OHENQANLQNOMAO-UHFFFAOYSA-N 0.000 description 6
• 239000003961 penetration enhancing agent Substances 0.000 description 6
• 230000000144 pharmacologic effect Effects 0.000 description 6
• 239000012071 phase Substances 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• 239000007921 spray Substances 0.000 description 6
• 239000004094 surface-active agent Substances 0.000 description 6
• 239000000375 suspending agent Substances 0.000 description 6
• 239000003765 sweetening agent Substances 0.000 description 6
• 238000011200 topical administration Methods 0.000 description 6
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
• XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• TZYWCYJVHRLUCT-VABKMULXSA-N N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal Chemical compound CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1 TZYWCYJVHRLUCT-VABKMULXSA-N 0.000 description 5
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
• 208000002474 Tinea Diseases 0.000 description 5
• 238000002835 absorbance Methods 0.000 description 5
• 238000010521 absorption reaction Methods 0.000 description 5
• 125000002252 acyl group Chemical group 0.000 description 5
• 239000007900 aqueous suspension Substances 0.000 description 5
• 238000006243 chemical reaction Methods 0.000 description 5
• 229940061627 chloromethyl methyl ether Drugs 0.000 description 5
• 239000003086 colorant Substances 0.000 description 5
• 235000014113 dietary fatty acids Nutrition 0.000 description 5
• 239000002552 dosage form Substances 0.000 description 5
• 239000000194 fatty acid Substances 0.000 description 5
• 229930195729 fatty acid Natural products 0.000 description 5
• 150000004665 fatty acids Chemical class 0.000 description 5
• 235000003599 food sweetener Nutrition 0.000 description 5
• 125000004474 heteroalkylene group Chemical group 0.000 description 5
• 125000004435 hydrogen atom Chemical class [H]* 0.000 description 5
• 230000005764 inhibitory process Effects 0.000 description 5
• 239000000543 intermediate Substances 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 5
• 230000003472 neutralizing effect Effects 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 230000035699 permeability Effects 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 239000011541 reaction mixture Substances 0.000 description 5
• 238000006467 substitution reaction Methods 0.000 description 5
• 235000015112 vegetable and seed oil Nutrition 0.000 description 5
• 239000008158 vegetable oil Substances 0.000 description 5
• 239000000080 wetting agent Substances 0.000 description 5
• KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
• HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 4
• KGSNDULZERXKSL-UHFFFAOYSA-N 2-[4-fluoro-2-(methoxymethoxymethyl)phenyl]-1,3,2-dioxaborolane Chemical compound COCOCC1=CC(F)=CC=C1B1OCCO1 KGSNDULZERXKSL-UHFFFAOYSA-N 0.000 description 4
• CJUCIKJLMFVWIS-UHFFFAOYSA-N 2-bromo-5-fluorobenzaldehyde Chemical compound FC1=CC=C(Br)C(C=O)=C1 CJUCIKJLMFVWIS-UHFFFAOYSA-N 0.000 description 4
• 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 4
• IUJMYOIVZXJKRJ-UHFFFAOYSA-N 6-fluoro-1-phenyl-3,4-dihydro-2,1-benzoxaborinine Chemical compound O1CCC2=CC(F)=CC=C2B1C1=CC=CC=C1 IUJMYOIVZXJKRJ-UHFFFAOYSA-N 0.000 description 4
• 241001225321 Aspergillus fumigatus Species 0.000 description 4
• 108010017384 Blood Proteins Proteins 0.000 description 4
• 102000004506 Blood Proteins Human genes 0.000 description 4
• 241000186216 Corynebacterium Species 0.000 description 4
• IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
• ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 4
• 241000893966 Trichophyton verrucosum Species 0.000 description 4
• 208000003152 Yellow Fever Diseases 0.000 description 4
• 230000000844 anti-bacterial effect Effects 0.000 description 4
• 235000010323 ascorbic acid Nutrition 0.000 description 4
• 239000011668 ascorbic acid Substances 0.000 description 4
• 229960005070 ascorbic acid Drugs 0.000 description 4
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
• 239000013553 cell monolayer Substances 0.000 description 4
• 229960003749 ciclopirox Drugs 0.000 description 4
• SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical compound ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 4
• RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 239000002270 dispersing agent Substances 0.000 description 4
• 125000001153 fluoro group Chemical group F* 0.000 description 4
• 235000013355 food flavoring agent Nutrition 0.000 description 4
• 244000053095 fungal pathogen Species 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 239000010410 layer Substances 0.000 description 4
• 230000007774 longterm Effects 0.000 description 4
• 239000002480 mineral oil Substances 0.000 description 4
• 235000010446 mineral oil Nutrition 0.000 description 4
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
• 229920001223 polyethylene glycol Polymers 0.000 description 4
• 239000000651 prodrug Substances 0.000 description 4
• 229940002612 prodrug Drugs 0.000 description 4
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
• 229920006395 saturated elastomer Polymers 0.000 description 4
• 238000001228 spectrum Methods 0.000 description 4
• 238000003756 stirring Methods 0.000 description 4
• 239000000516 sunscreening agent Substances 0.000 description 4
• 239000003826 tablet Substances 0.000 description 4
• 238000002560 therapeutic procedure Methods 0.000 description 4
• 230000037317 transdermal delivery Effects 0.000 description 4
• IOWGHQGLUMEZKG-UHFFFAOYSA-N (2-bromophenyl)methanol Chemical class OCC1=CC=CC=C1Br IOWGHQGLUMEZKG-UHFFFAOYSA-N 0.000 description 3
• ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 3
• DIZPEZNNOODNQE-UHFFFAOYSA-N 1-bromo-2-(methoxymethoxymethyl)benzene Chemical compound COCOCC1=CC=CC=C1Br DIZPEZNNOODNQE-UHFFFAOYSA-N 0.000 description 3
• DWRMHMOLSZZYDZ-UHFFFAOYSA-N 1-bromo-4-fluoro-2-(methoxymethoxymethyl)benzene Chemical compound COCOCC1=CC(F)=CC=C1Br DWRMHMOLSZZYDZ-UHFFFAOYSA-N 0.000 description 3
• ATWHLVHDDXTKFJ-UHFFFAOYSA-N 1-bromo-4-fluoro-2-[2-(methoxymethoxy)ethyl]benzene Chemical compound COCOCCC1=CC(F)=CC=C1Br ATWHLVHDDXTKFJ-UHFFFAOYSA-N 0.000 description 3
• VHXQOTONQHOYAZ-UHFFFAOYSA-N 1-phenyl-3,4-dihydro-2,1-benzoxaborinine Chemical compound O1CCC2=CC=CC=C2B1C1=CC=CC=C1 VHXQOTONQHOYAZ-UHFFFAOYSA-N 0.000 description 3
• ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 3
• IOOWNWLVCOUUEX-WPRPVWTQSA-N 2-[(3r,6s)-2-hydroxy-3-[(2-thiophen-2-ylacetyl)amino]oxaborinan-6-yl]acetic acid Chemical compound OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1 IOOWNWLVCOUUEX-WPRPVWTQSA-N 0.000 description 3
• QDHRSLFSDGCJFX-UHFFFAOYSA-N 3-fluorobenzyl alcohol Chemical compound OCC1=CC=CC(F)=C1 QDHRSLFSDGCJFX-UHFFFAOYSA-N 0.000 description 3
• 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 3
• OJZIIAHGEBFDRF-UHFFFAOYSA-N 4-bromo-3-(methoxymethoxymethyl)benzonitrile Chemical compound COCOCC1=CC(C#N)=CC=C1Br OJZIIAHGEBFDRF-UHFFFAOYSA-N 0.000 description 3
• 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 3
• HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
• ZMGMFGMCMVSJLI-UHFFFAOYSA-N 5-bromo-2-fluoro-5-[1-(methoxymethoxy)ethyl]cyclohexa-1,3-diene Chemical compound BrC1(CC=C(C=C1)F)C(C)OCOC ZMGMFGMCMVSJLI-UHFFFAOYSA-N 0.000 description 3
• 241000272517 Anseriformes Species 0.000 description 3
• 208000035143 Bacterial infection Diseases 0.000 description 3
• 241000588807 Bordetella Species 0.000 description 3
• 239000004322 Butylated hydroxytoluene Substances 0.000 description 3
• NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• 201000007336 Cryptococcosis Diseases 0.000 description 3
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
• 241001480035 Epidermophyton Species 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• 241000282326 Felis catus Species 0.000 description 3
• 241000287828 Gallus gallus Species 0.000 description 3
• 241000699694 Gerbillinae Species 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 108010076876 Keratins Proteins 0.000 description 3
• 102000011782 Keratins Human genes 0.000 description 3
• 231100000111 LD50 Toxicity 0.000 description 3
• 241000555688 Malassezia furfur Species 0.000 description 3
• 241000893976 Nannizzia gypsea Species 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 241001494479 Pecora Species 0.000 description 3
• 239000004264 Petrolatum Substances 0.000 description 3
• 241000223960 Plasmodium falciparum Species 0.000 description 3
• 239000002202 Polyethylene glycol Substances 0.000 description 3
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
• 235000021355 Stearic acid Nutrition 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
• 241000223238 Trichophyton Species 0.000 description 3
• 241000223104 Trypanosoma Species 0.000 description 3
• 208000036142 Viral infection Diseases 0.000 description 3
• OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 3
• 230000002378 acidificating effect Effects 0.000 description 3
• 229960002916 adapalene Drugs 0.000 description 3
• LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 3
• 235000010443 alginic acid Nutrition 0.000 description 3
• 229920000615 alginic acid Polymers 0.000 description 3
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 125000000129 anionic group Chemical group 0.000 description 3
• 239000008346 aqueous phase Substances 0.000 description 3
• 208000022362 bacterial infectious disease Diseases 0.000 description 3
• ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 3
• 244000309464 bull Species 0.000 description 3
• 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
• 229940095259 butylated hydroxytoluene Drugs 0.000 description 3
• 229910000019 calcium carbonate Inorganic materials 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 229910000389 calcium phosphate Inorganic materials 0.000 description 3
• 235000011010 calcium phosphates Nutrition 0.000 description 3
• 230000010261 cell growth Effects 0.000 description 3
• 235000013330 chicken meat Nutrition 0.000 description 3
• 229910052801 chlorine Inorganic materials 0.000 description 3
• 229940126214 compound 3 Drugs 0.000 description 3
• 125000004122 cyclic group Chemical group 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• 235000005911 diet Nutrition 0.000 description 3
• 230000037213 diet Effects 0.000 description 3
• 238000009792 diffusion process Methods 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 239000003651 drinking water Substances 0.000 description 3
• 235000020188 drinking water Nutrition 0.000 description 3
• 210000002615 epidermis Anatomy 0.000 description 3
• 229910052731 fluorine Inorganic materials 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 229940075507 glyceryl monostearate Drugs 0.000 description 3
• 229930195733 hydrocarbon Natural products 0.000 description 3
• 150000002430 hydrocarbons Chemical group 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 239000004922 lacquer Substances 0.000 description 3
• 229940057995 liquid paraffin Drugs 0.000 description 3
• NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 description 3
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
• 229960002216 methylparaben Drugs 0.000 description 3
• 239000012046 mixed solvent Substances 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 125000004433 nitrogen atom Chemical group N* 0.000 description 3
• 239000002736 nonionic surfactant Substances 0.000 description 3
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
• 239000004006 olive oil Substances 0.000 description 3
• 235000008390 olive oil Nutrition 0.000 description 3
• 229940066842 petrolatum Drugs 0.000 description 3
• 235000019271 petrolatum Nutrition 0.000 description 3
• 230000000704 physical effect Effects 0.000 description 3
• 239000013641 positive control Substances 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 235000011069 sorbitan monooleate Nutrition 0.000 description 3
• 239000001593 sorbitan monooleate Substances 0.000 description 3
• 229940035049 sorbitan monooleate Drugs 0.000 description 3
• 239000008117 stearic acid Substances 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 125000004434 sulfur atom Chemical group 0.000 description 3
• 230000000475 sunscreen effect Effects 0.000 description 3
• 238000013268 sustained release Methods 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• 239000006188 syrup Substances 0.000 description 3
• 235000020357 syrup Nutrition 0.000 description 3
• 229960000565 tazarotene Drugs 0.000 description 3
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
• 231100000419 toxicity Toxicity 0.000 description 3
• 230000001988 toxicity Effects 0.000 description 3
• 229960001727 tretinoin Drugs 0.000 description 3
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
• 230000009385 viral infection Effects 0.000 description 3
• 239000001993 wax Substances 0.000 description 3
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
• YOLUSOFTODTRQV-UHFFFAOYSA-N (2-bromo-5-chlorophenyl)methanol Chemical compound OCC1=CC(Cl)=CC=C1Br YOLUSOFTODTRQV-UHFFFAOYSA-N 0.000 description 2
• YBBLBTIEJDXXEG-UHFFFAOYSA-N 1-bromo-2,4-bis(methoxymethoxymethyl)benzene Chemical compound COCOCC1=CC=C(Br)C(COCOC)=C1 YBBLBTIEJDXXEG-UHFFFAOYSA-N 0.000 description 2
• MICXSWCQEMESAN-UHFFFAOYSA-N 1-bromo-2-(methoxymethoxymethyl)-4-methylbenzene Chemical compound COCOCC1=CC(C)=CC=C1Br MICXSWCQEMESAN-UHFFFAOYSA-N 0.000 description 2
• YIHFZZAUSZFESU-UHFFFAOYSA-N 1-bromo-2-(methoxymethoxymethyl)naphthalene Chemical compound C1=CC=CC2=C(Br)C(COCOC)=CC=C21 YIHFZZAUSZFESU-UHFFFAOYSA-N 0.000 description 2
• AUAKHKPWJUAQBK-UHFFFAOYSA-N 1-bromo-2-[2-(methoxymethoxy)ethyl]benzene Chemical compound COCOCCC1=CC=CC=C1Br AUAKHKPWJUAQBK-UHFFFAOYSA-N 0.000 description 2
• VHGIRMPYUVXOAR-UHFFFAOYSA-N 1-bromo-4,5-difluoro-2-(methoxymethoxymethyl)benzene Chemical compound COCOCC1=CC(F)=C(F)C=C1Br VHGIRMPYUVXOAR-UHFFFAOYSA-N 0.000 description 2
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
• 238000005160 1H NMR spectroscopy Methods 0.000 description 2
• HNURKXXMYARGAY-UHFFFAOYSA-N 2,6-Di-tert-butyl-4-hydroxymethylphenol Chemical compound CC(C)(C)C1=CC(CO)=CC(C(C)(C)C)=C1O HNURKXXMYARGAY-UHFFFAOYSA-N 0.000 description 2
• CSZAWKYBHOEQQD-UHFFFAOYSA-N 2-(2-bromo-5-fluorophenyl)acetaldehyde Chemical compound FC1=CC=C(Br)C(CC=O)=C1 CSZAWKYBHOEQQD-UHFFFAOYSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
• 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 2
• 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 2
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
• MKEWOMLQLUYQPK-UHFFFAOYSA-N 4-bromo-3-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC(C#N)=CC=C1Br MKEWOMLQLUYQPK-UHFFFAOYSA-N 0.000 description 2
• CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
• OBHRHSYGQBYLNH-UHFFFAOYSA-N 6-fluoro-1-hydroxy-3,4-dihydro-2,1-benzoxaborinine Chemical compound FC1=CC=C2B(O)OCCC2=C1 OBHRHSYGQBYLNH-UHFFFAOYSA-N 0.000 description 2
• 244000215068 Acacia senegal Species 0.000 description 2
• 235000006491 Acacia senegal Nutrition 0.000 description 2
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
• 208000002874 Acne Vulgaris Diseases 0.000 description 2
• 241000186046 Actinomyces Species 0.000 description 2
• 241000589158 Agrobacterium Species 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• 102000009027 Albumins Human genes 0.000 description 2
• 241001116389 Aloe Species 0.000 description 2
• 201000004384 Alopecia Diseases 0.000 description 2
• 206010001935 American trypanosomiasis Diseases 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 241000228212 Aspergillus Species 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• YCEGGNNGACCHFZ-UHFFFAOYSA-N B1OC=CC=C1 Chemical compound B1OC=CC=C1 YCEGGNNGACCHFZ-UHFFFAOYSA-N 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 239000005711 Benzoic acid Substances 0.000 description 2
• 241000589562 Brucella Species 0.000 description 2
• 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
• 0 CC(*)CC(*)c1ccccc1B(*#I)OC(C)(*1)C1=* Chemical compound CC(*)CC(*)c1ccccc1B(*#I)OC(C)(*1)C1=* 0.000 description 2
• 241000589876 Campylobacter Species 0.000 description 2
• 241000589874 Campylobacter fetus Species 0.000 description 2
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
• 241000222173 Candida parapsilosis Species 0.000 description 2
• 241000222178 Candida tropicalis Species 0.000 description 2
• 241000700199 Cavia porcellus Species 0.000 description 2
• 241000282994 Cervidae Species 0.000 description 2
• 241000193403 Clostridium Species 0.000 description 2
• 241000272201 Columbiformes Species 0.000 description 2
• 241000711573 Coronaviridae Species 0.000 description 2
• 241000588914 Enterobacter Species 0.000 description 2
• 241001480036 Epidermophyton floccosum Species 0.000 description 2
• 241000283086 Equidae Species 0.000 description 2
• 206010015150 Erythema Diseases 0.000 description 2
• 241000588722 Escherichia Species 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• 208000002584 Fungal Eye Infections Diseases 0.000 description 2
• 241000223218 Fusarium Species 0.000 description 2
• 241000427940 Fusarium solani Species 0.000 description 2
• IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 206010018612 Gonorrhoea Diseases 0.000 description 2
• 229920000084 Gum arabic Polymers 0.000 description 2
• 208000031886 HIV Infections Diseases 0.000 description 2
• 241000606790 Haemophilus Species 0.000 description 2
• 241000589989 Helicobacter Species 0.000 description 2
• 208000007514 Herpes zoster Diseases 0.000 description 2
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 2
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 241000588748 Klebsiella Species 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• 241001299738 Malassezia pachydermatis Species 0.000 description 2
• 241001291478 Malassezia sympodialis Species 0.000 description 2
• 208000003351 Melanosis Diseases 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• 241001480037 Microsporum Species 0.000 description 2
• 241001480000 Microsporum audouinii Species 0.000 description 2
• 241000893980 Microsporum canis Species 0.000 description 2
• 241000186359 Mycobacterium Species 0.000 description 2
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
• 101710144111 Non-structural protein 3 Proteins 0.000 description 2
• 241000272458 Numididae Species 0.000 description 2
• 241000712464 Orthomyxoviridae Species 0.000 description 2
• 241000606860 Pasteurella Species 0.000 description 2
• 235000019483 Peanut oil Nutrition 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 241000235645 Pichia kudriavzevii Species 0.000 description 2
• 108010076039 Polyproteins Proteins 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 241000186429 Propionibacterium Species 0.000 description 2
• 241000589516 Pseudomonas Species 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• 241000283011 Rangifer Species 0.000 description 2
• 241000282849 Ruminantia Species 0.000 description 2
• 241000315672 SARS coronavirus Species 0.000 description 2
• 241000607142 Salmonella Species 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 241000187747 Streptomyces Species 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• WPMWEFXCIYCJSA-UHFFFAOYSA-N Tetraethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCO WPMWEFXCIYCJSA-UHFFFAOYSA-N 0.000 description 2
• 229920001615 Tragacanth Polymers 0.000 description 2
• 241001480048 Trichophyton tonsurans Species 0.000 description 2
• 241000223109 Trypanosoma cruzi Species 0.000 description 2
• 208000037386 Typhoid Diseases 0.000 description 2
• 108090000848 Ubiquitin Proteins 0.000 description 2
• 102000044159 Ubiquitin Human genes 0.000 description 2
• 241000607598 Vibrio Species 0.000 description 2
• 229930003427 Vitamin E Natural products 0.000 description 2
• 241000607479 Yersinia pestis Species 0.000 description 2
• XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
• 235000010489 acacia gum Nutrition 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 206010000496 acne Diseases 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 230000002411 adverse Effects 0.000 description 2
• 150000001298 alcohols Chemical class 0.000 description 2
• 239000000783 alginic acid Substances 0.000 description 2
• 229960001126 alginic acid Drugs 0.000 description 2
• 150000004781 alginic acids Chemical class 0.000 description 2
• 235000011399 aloe vera Nutrition 0.000 description 2
• 231100000360 alopecia Toxicity 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 239000002280 amphoteric surfactant Substances 0.000 description 2
• 239000003945 anionic surfactant Substances 0.000 description 2
• 150000001450 anions Chemical class 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 230000003712 anti-aging effect Effects 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
• 235000010233 benzoic acid Nutrition 0.000 description 2
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 230000008499 blood brain barrier function Effects 0.000 description 2
• 210000001218 blood-brain barrier Anatomy 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 150000001639 boron compounds Chemical class 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 239000006172 buffering agent Substances 0.000 description 2
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
• 229940043253 butylated hydroxyanisole Drugs 0.000 description 2
• CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
• LWQQLNNNIPYSNX-UROSTWAQSA-N calcipotriol Chemical compound C1([C@H](O)/C=C/[C@@H](C)[C@@H]2[C@]3(CCCC(/[C@@H]3CC2)=C\C=C\2C([C@@H](O)C[C@H](O)C/2)=C)C)CC1 LWQQLNNNIPYSNX-UROSTWAQSA-N 0.000 description 2
• 229960002882 calcipotriol Drugs 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 229940095731 candida albicans Drugs 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 239000012876 carrier material Substances 0.000 description 2
• 125000002091 cationic group Chemical group 0.000 description 2
• 239000003093 cationic surfactant Substances 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 239000006184 cosolvent Substances 0.000 description 2
• 239000012043 crude product Substances 0.000 description 2
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 229940120503 dihydroxyacetone Drugs 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• 206010013023 diphtheria Diseases 0.000 description 2
• 239000000890 drug combination Substances 0.000 description 2
• 230000036267 drug metabolism Effects 0.000 description 2
• 229950007919 egtazic acid Drugs 0.000 description 2
• 231100000321 erythema Toxicity 0.000 description 2
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 230000029142 excretion Effects 0.000 description 2
• 239000003925 fat Substances 0.000 description 2
• 235000019197 fats Nutrition 0.000 description 2
• 238000003818 flash chromatography Methods 0.000 description 2
• 229960004884 fluconazole Drugs 0.000 description 2
• RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 208000024386 fungal infectious disease Diseases 0.000 description 2
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 208000001786 gonorrhea Diseases 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 229940093915 gynecological organic acid Drugs 0.000 description 2
• 125000001188 haloalkyl group Chemical group 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 2
• 208000029080 human African trypanosomiasis Diseases 0.000 description 2
• JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
• 239000012442 inert solvent Substances 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 230000004054 inflammatory process Effects 0.000 description 2
• 239000002054 inoculum Substances 0.000 description 2
• 230000000968 intestinal effect Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
• KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 150000002611 lead compounds Chemical class 0.000 description 2
• 235000010445 lecithin Nutrition 0.000 description 2
• 239000000787 lecithin Substances 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
• WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 2
• 231100000053 low toxicity Toxicity 0.000 description 2
• 239000007937 lozenge Substances 0.000 description 2
• RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 2
• 201000004792 malaria Diseases 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 229910021645 metal ion Inorganic materials 0.000 description 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
• 229920000609 methyl cellulose Polymers 0.000 description 2
• 235000010981 methylcellulose Nutrition 0.000 description 2
• 239000001923 methylcellulose Substances 0.000 description 2
• 230000003228 microsomal effect Effects 0.000 description 2
• 238000013508 migration Methods 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 208000026721 nail disease Diseases 0.000 description 2
• 231100000344 non-irritating Toxicity 0.000 description 2
• 239000000346 nonvolatile oil Substances 0.000 description 2
• QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
• 239000000312 peanut oil Substances 0.000 description 2
• 230000000149 penetrating effect Effects 0.000 description 2
• DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
• HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
• XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
• 238000007747 plating Methods 0.000 description 2
• 239000002798 polar solvent Substances 0.000 description 2
• 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
• 229920000053 polysorbate 80 Polymers 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 239000002244 precipitate Substances 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 230000001737 promoting effect Effects 0.000 description 2
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
• 239000000473 propyl gallate Substances 0.000 description 2
• 235000010388 propyl gallate Nutrition 0.000 description 2
• 229940075579 propyl gallate Drugs 0.000 description 2
• 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
• 229960003415 propylparaben Drugs 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 210000000664 rectum Anatomy 0.000 description 2
• 230000000241 respiratory effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 238000002390 rotary evaporation Methods 0.000 description 2
• 229960004889 salicylic acid Drugs 0.000 description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 238000013207 serial dilution Methods 0.000 description 2
• 235000015424 sodium Nutrition 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 235000010413 sodium alginate Nutrition 0.000 description 2
• 239000000661 sodium alginate Substances 0.000 description 2
• 229940005550 sodium alginate Drugs 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000011550 stock solution Substances 0.000 description 2
• TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 208000006379 syphilis Diseases 0.000 description 2
• 238000007910 systemic administration Methods 0.000 description 2
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
• 125000005309 thioalkoxy group Chemical group 0.000 description 2
• 239000003104 tissue culture media Substances 0.000 description 2
• 210000004906 toe nail Anatomy 0.000 description 2
• 231100000816 toxic dose Toxicity 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
• 238000001665 trituration Methods 0.000 description 2
• 201000008297 typhoid fever Diseases 0.000 description 2
• 125000004417 unsaturated alkyl group Chemical group 0.000 description 2
• 229940088594 vitamin Drugs 0.000 description 2
• 229930003231 vitamin Natural products 0.000 description 2
• 235000013343 vitamin Nutrition 0.000 description 2
• 239000011782 vitamin Substances 0.000 description 2
• 235000019165 vitamin E Nutrition 0.000 description 2
• 229940046009 vitamin E Drugs 0.000 description 2
• 239000011709 vitamin E Substances 0.000 description 2
• 239000012224 working solution Substances 0.000 description 2
• WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
• RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 1
• RGEMJCLUPGZKTQ-WAUHAFJUSA-N (3s,8r,9s,10r,13s,14s)-3-[2-(dimethylamino)ethoxy]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one Chemical compound C([C@@H]12)C[C@]3(C)C(=O)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OCCN(C)C)C1 RGEMJCLUPGZKTQ-WAUHAFJUSA-N 0.000 description 1
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
• 125000000196 1,4-pentadienyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])=C([H])[H] 0.000 description 1
• SRUQARLMFOLRDN-UHFFFAOYSA-N 1-(2,4,5-Trihydroxyphenyl)-1-butanone Chemical compound CCCC(=O)C1=CC(O)=C(O)C=C1O SRUQARLMFOLRDN-UHFFFAOYSA-N 0.000 description 1
• AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
• YHOHYGRMAGLZNT-UHFFFAOYSA-N 1-bromo-2-(methoxymethoxymethyl)-4-(trifluoromethyl)benzene Chemical compound COCOCC1=CC(C(F)(F)F)=CC=C1Br YHOHYGRMAGLZNT-UHFFFAOYSA-N 0.000 description 1
• LHUQPFVKMNWSSI-UHFFFAOYSA-N 1-bromo-2h-naphthalene-1-carbaldehyde Chemical compound C1=CC=C2C(Br)(C=O)CC=CC2=C1 LHUQPFVKMNWSSI-UHFFFAOYSA-N 0.000 description 1
• QQBYSVGVCORKNY-UHFFFAOYSA-N 1-bromo-3-fluoro-2-(methoxymethoxymethyl)benzene Chemical compound COCOCC1=C(F)C=CC=C1Br QQBYSVGVCORKNY-UHFFFAOYSA-N 0.000 description 1
• KVDNNBDHBSSKNZ-UHFFFAOYSA-N 1-bromo-4-methoxy-2-(methoxymethoxymethyl)benzene Chemical compound COCOCC1=CC(OC)=CC=C1Br KVDNNBDHBSSKNZ-UHFFFAOYSA-N 0.000 description 1
• CKEWCFGVNDVQSC-UHFFFAOYSA-N 1-hydroxy-3,4-dihydro-2,1-benzoxaborinine Chemical compound C1=CC=C2B(O)OCCC2=C1 CKEWCFGVNDVQSC-UHFFFAOYSA-N 0.000 description 1
• 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
• LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
• 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
• AXBFWAWZAFWFQW-UHFFFAOYSA-N 2-(2-bromophenyl)acetaldehyde Chemical compound BrC1=CC=CC=C1CC=O AXBFWAWZAFWFQW-UHFFFAOYSA-N 0.000 description 1
• OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
• UGDAWAQEKLURQI-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethanol;hydrate Chemical compound O.OCCOCCO UGDAWAQEKLURQI-UHFFFAOYSA-N 0.000 description 1
• WGIMXKDCVCTHGW-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCO WGIMXKDCVCTHGW-UHFFFAOYSA-N 0.000 description 1
• SOMXNDSBWQEJGE-UHFFFAOYSA-N 2-(2-phenylethenyl)-1,3,2-dioxaborolane Chemical compound O1CCOB1C=CC1=CC=CC=C1 SOMXNDSBWQEJGE-UHFFFAOYSA-N 0.000 description 1
• JOXJSNMBKNEDTQ-UHFFFAOYSA-N 2-(3-chlorophenyl)-1,3,2-dioxaborolane Chemical compound ClC1=CC=CC(B2OCCO2)=C1 JOXJSNMBKNEDTQ-UHFFFAOYSA-N 0.000 description 1
• AMROMNCFBJPUEB-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3,2-dioxaborolane Chemical compound FC1=CC=CC(B2OCCO2)=C1 AMROMNCFBJPUEB-UHFFFAOYSA-N 0.000 description 1
• GSVGCTFELKEEPC-UHFFFAOYSA-N 2-(3-methylphenyl)-1,3,2-dioxaborolane Chemical compound CC1=CC=CC(B2OCCO2)=C1 GSVGCTFELKEEPC-UHFFFAOYSA-N 0.000 description 1
• ZDANMRXRFANFKM-UHFFFAOYSA-N 2-(4-chlorophenyl)-1,3,2-dioxaborolane Chemical compound C1=CC(Cl)=CC=C1B1OCCO1 ZDANMRXRFANFKM-UHFFFAOYSA-N 0.000 description 1
• QBBPVRDQYXXGDG-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3,2-dioxaborolane Chemical compound C1=CC(F)=CC=C1B1OCCO1 QBBPVRDQYXXGDG-UHFFFAOYSA-N 0.000 description 1
• DPHMAABLNKUQHP-UHFFFAOYSA-N 2-(4-methylthiophen-3-yl)-1,3,2-dioxaborolane Chemical compound CC1=CSC=C1B1OCCO1 DPHMAABLNKUQHP-UHFFFAOYSA-N 0.000 description 1
• FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
• VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
• 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
• DGCBGBZYTNTZJH-UHFFFAOYSA-N 2-bromo-4,5-difluorobenzoic acid Chemical compound OC(=O)C1=CC(F)=C(F)C=C1Br DGCBGBZYTNTZJH-UHFFFAOYSA-N 0.000 description 1
• ALJWIUYVYZYOBZ-UHFFFAOYSA-N 2-bromo-4-fluoro-1-(methoxymethoxymethyl)benzene Chemical compound COCOCC1=CC=C(F)C=C1Br ALJWIUYVYZYOBZ-UHFFFAOYSA-N 0.000 description 1
• RRKPMLZRLKTDQV-UHFFFAOYSA-N 2-bromo-4-fluorobenzoic acid Chemical compound OC(=O)C1=CC=C(F)C=C1Br RRKPMLZRLKTDQV-UHFFFAOYSA-N 0.000 description 1
• CSOBJYGHQOLWOD-UHFFFAOYSA-N 2-bromo-5-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(Br)C(C=O)=C1 CSOBJYGHQOLWOD-UHFFFAOYSA-N 0.000 description 1
• RBCPJQQJBAQSOU-UHFFFAOYSA-N 2-bromo-5-chlorobenzoic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1Br RBCPJQQJBAQSOU-UHFFFAOYSA-N 0.000 description 1
• ODHJOROUCITYNF-UHFFFAOYSA-N 2-bromo-5-methoxybenzoic acid Chemical compound COC1=CC=C(Br)C(C(O)=O)=C1 ODHJOROUCITYNF-UHFFFAOYSA-N 0.000 description 1
• ZXMISUUIYPFORW-UHFFFAOYSA-N 2-bromo-5-methylbenzoic acid Chemical compound CC1=CC=C(Br)C(C(O)=O)=C1 ZXMISUUIYPFORW-UHFFFAOYSA-N 0.000 description 1
• MDAZJVAIZVUWDE-UHFFFAOYSA-N 2-bromo-6-fluorobenzoic acid Chemical compound OC(=O)C1=C(F)C=CC=C1Br MDAZJVAIZVUWDE-UHFFFAOYSA-N 0.000 description 1
• 125000006280 2-bromobenzyl group Chemical group [H]C1=C([H])C(Br)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
• RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
• HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
• 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
• ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
• HVEMPDZEMICSMG-UHFFFAOYSA-N 2-phenyl-1,3,2-dioxaborolane Chemical compound O1CCOB1C1=CC=CC=C1 HVEMPDZEMICSMG-UHFFFAOYSA-N 0.000 description 1
• 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
• 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
• IQMJICFRSJNWDC-UHFFFAOYSA-N 2-thiophen-3-yl-1,3,2-dioxaborolane Chemical compound O1CCOB1C1=CSC=C1 IQMJICFRSJNWDC-UHFFFAOYSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 1
• 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
• 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
• ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
• 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
• KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
• UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
• CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• LDIOUQIXNSSOGU-UHFFFAOYSA-N 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[d]pyrazolo[1,5-a]pyrimidine Chemical compound CC1=NN2C(NC(CC)CC)=C3CCCC3=NC2=C1C1=CC=C(OC)C=C1Cl LDIOUQIXNSSOGU-UHFFFAOYSA-N 0.000 description 1
• 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 206010063409 Acarodermatitis Diseases 0.000 description 1
• 241000589291 Acinetobacter Species 0.000 description 1
• 241000588626 Acinetobacter baumannii Species 0.000 description 1
• 206010056508 Acquired epidermolysis bullosa Diseases 0.000 description 1
• 241000186361 Actinobacteria <class> Species 0.000 description 1
• 241000186041 Actinomyces israelii Species 0.000 description 1
• 208000000230 African Trypanosomiasis Diseases 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
• VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical class NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 241000223600 Alternaria Species 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• 208000004881 Amebiasis Diseases 0.000 description 1
• 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 1
• 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 206010001980 Amoebiasis Diseases 0.000 description 1
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
• 241000272525 Anas platyrhynchos Species 0.000 description 1
• 241000272814 Anser sp. Species 0.000 description 1
• 235000003911 Arachis Nutrition 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 240000005528 Arctium lappa Species 0.000 description 1
• 201000002909 Aspergillosis Diseases 0.000 description 1
• 241000228197 Aspergillus flavus Species 0.000 description 1
• 208000036641 Aspergillus infections Diseases 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 241000304886 Bacilli Species 0.000 description 1
• 241000193738 Bacillus anthracis Species 0.000 description 1
• 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
• 239000004342 Benzoyl peroxide Substances 0.000 description 1
• OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
• 241000335423 Blastomyces Species 0.000 description 1
• 241000228405 Blastomyces dermatitidis Species 0.000 description 1
• 241001416153 Bos grunniens Species 0.000 description 1
• 208000003508 Botulism Diseases 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 241000589567 Brucella abortus Species 0.000 description 1
• 206010006500 Brucellosis Diseases 0.000 description 1
• 241000195940 Bryophyta Species 0.000 description 1
• QUMCIHKVKQYNPA-RUZDIDTESA-N C1(CCCCC1)CN1[C@@H](C=2N(C=3C=NC(=NC1=3)NC1=C(C=C(C(=O)NC3CCN(CC3)C)C=C1)OC)C(=NN=2)C)CC Chemical compound C1(CCCCC1)CN1[C@@H](C=2N(C=3C=NC(=NC1=3)NC1=C(C=C(C(=O)NC3CCN(CC3)C)C=C1)OC)C(=NN=2)C)CC QUMCIHKVKQYNPA-RUZDIDTESA-N 0.000 description 1
• ILGMTCNKYFMEFV-UHFFFAOYSA-N C1=CC=C2C=CBOC2=C1 Chemical class C1=CC=C2C=CBOC2=C1 ILGMTCNKYFMEFV-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282832 Camelidae Species 0.000 description 1
• 244000197813 Camelina sativa Species 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• 241000589875 Campylobacter jejuni Species 0.000 description 1
• 206010007134 Candida infections Diseases 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 206010007882 Cellulitis Diseases 0.000 description 1
• 208000024699 Chagas disease Diseases 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 241001647378 Chlamydia psittaci Species 0.000 description 1
• 241000606153 Chlamydia trachomatis Species 0.000 description 1
• GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
• KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
• 206010008631 Cholera Diseases 0.000 description 1
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
• 241000193163 Clostridioides difficile Species 0.000 description 1
• 241000193155 Clostridium botulinum Species 0.000 description 1
• 241000193468 Clostridium perfringens Species 0.000 description 1
• 241000193449 Clostridium tetani Species 0.000 description 1
• 241000223205 Coccidioides immitis Species 0.000 description 1
• ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 206010010741 Conjunctivitis Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
• 208000008953 Cryptosporidiosis Diseases 0.000 description 1
• 206010011502 Cryptosporidiosis infection Diseases 0.000 description 1
• 241000223936 Cryptosporidium parvum Species 0.000 description 1
• 206010011684 Cutaneous tuberculosis Diseases 0.000 description 1
• 241000186427 Cutibacterium acnes Species 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
• 206010011985 Decubitus ulcer Diseases 0.000 description 1
• 241000725619 Dengue virus Species 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 206010012442 Dermatitis contact Diseases 0.000 description 1
• 206010048768 Dermatosis Diseases 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
• 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 241000710188 Encephalomyocarditis virus Species 0.000 description 1
• 206010014666 Endocarditis bacterial Diseases 0.000 description 1
• 241000224432 Entamoeba histolytica Species 0.000 description 1
• 241000194033 Enterococcus Species 0.000 description 1
• 241000194032 Enterococcus faecalis Species 0.000 description 1
• 241000194031 Enterococcus faecium Species 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 208000032541 Epidermal naevus Diseases 0.000 description 1
• 201000000297 Erysipelas Diseases 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 108090000331 Firefly luciferases Proteins 0.000 description 1
• 241000192125 Firmicutes Species 0.000 description 1
• 241000710781 Flaviviridae Species 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 241000589602 Francisella tularensis Species 0.000 description 1
• 208000014260 Fungal keratitis Diseases 0.000 description 1
• 206010017711 Gangrene Diseases 0.000 description 1
• 241001427367 Gardena Species 0.000 description 1
• 208000005577 Gastroenteritis Diseases 0.000 description 1
• 241000237858 Gastropoda Species 0.000 description 1
• 241000224467 Giardia intestinalis Species 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 206010018691 Granuloma Diseases 0.000 description 1
• 239000007818 Grignard reagent Substances 0.000 description 1
• 241000147041 Guaiacum officinale Species 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 241000590002 Helicobacter pylori Species 0.000 description 1
• 241000711549 Hepacivirus C Species 0.000 description 1
• 241000700739 Hepadnaviridae Species 0.000 description 1
• 206010019851 Hepatotoxicity Diseases 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 241000700586 Herpesviridae Species 0.000 description 1
• 241000228402 Histoplasma Species 0.000 description 1
• 241000228404 Histoplasma capsulatum Species 0.000 description 1
• 201000002563 Histoplasmosis Diseases 0.000 description 1
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
• 241000430519 Human rhinovirus sp. Species 0.000 description 1
• 208000030148 Inflammatory linear verrucous epidermal nevus Diseases 0.000 description 1
• 208000002078 Ingrown Nails Diseases 0.000 description 1
• 102100040018 Interferon alpha-2 Human genes 0.000 description 1
• 108010079944 Interferon-alpha2b Proteins 0.000 description 1
• 108010025815 Kanamycin Kinase Proteins 0.000 description 1
• QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
• 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
• 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 239000004166 Lanolin Substances 0.000 description 1
• 241000589242 Legionella pneumophila Species 0.000 description 1
• 208000004023 Legionellosis Diseases 0.000 description 1
• 241000222738 Leishmania aethiopica Species 0.000 description 1
• 241000222724 Leishmania amazonensis Species 0.000 description 1
• 241000178949 Leishmania chagasi Species 0.000 description 1
• 241000222697 Leishmania infantum Species 0.000 description 1
• 241000012072 Leishmania mexicana venezuelensis Species 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 244000207740 Lemna minor Species 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 206010024238 Leptospirosis Diseases 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
• 239000000232 Lipid Bilayer Substances 0.000 description 1
• 241001233242 Lontra Species 0.000 description 1
• 241000406668 Loxodonta cyclotis Species 0.000 description 1
• 241000428198 Lutrinae Species 0.000 description 1
• 241000555676 Malassezia Species 0.000 description 1
• 241001291474 Malassezia globosa Species 0.000 description 1
• 241001291477 Malassezia restricta Species 0.000 description 1
• 241001291475 Malassezia slooffiae Species 0.000 description 1
• 206010027202 Meningitis bacterial Diseases 0.000 description 1
• LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical class SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
• 241000235048 Meyerozyma guilliermondii Species 0.000 description 1
• BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
• 241001260008 Microsporum equinum Species 0.000 description 1
• 241000545499 Mycobacterium avium-intracellulare Species 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
• 206010061303 Nail bed infection Diseases 0.000 description 1
• 206010028698 Nail dystrophy Diseases 0.000 description 1
• 206010028703 Nail psoriasis Diseases 0.000 description 1
• 208000000592 Nasal Polyps Diseases 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 241000588650 Neisseria meningitidis Species 0.000 description 1
• 241001045988 Neogene Species 0.000 description 1
• DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• 239000006057 Non-nutritive feed additive Substances 0.000 description 1
• 101800001020 Non-structural protein 4A Proteins 0.000 description 1
• 101800001019 Non-structural protein 4B Proteins 0.000 description 1
• 101800001014 Non-structural protein 5A Proteins 0.000 description 1
• 244000020186 Nymphaea lutea Species 0.000 description 1
• LIGKOZHDSGAHME-UHFFFAOYSA-N OB1OCc2cccc(F)c12 Chemical compound OB1OCc2cccc(F)c12 LIGKOZHDSGAHME-UHFFFAOYSA-N 0.000 description 1
• YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 206010033078 Otitis media Diseases 0.000 description 1
• 206010033372 Pain and discomfort Diseases 0.000 description 1
• 241000845082 Panama Species 0.000 description 1
• 206010033767 Paracoccidioides infections Diseases 0.000 description 1
• 201000000301 Paracoccidioidomycosis Diseases 0.000 description 1
• 208000005775 Parakeratosis Diseases 0.000 description 1
• 241000711504 Paramyxoviridae Species 0.000 description 1
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 241000721454 Pemphigus Species 0.000 description 1
• 241000228143 Penicillium Species 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• 201000005702 Pertussis Diseases 0.000 description 1
• 206010034839 Pharyngitis streptococcal Diseases 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 241000222831 Phialophora <Chaetothyriales> Species 0.000 description 1
• 240000009188 Phyllostachys vivax Species 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 206010035148 Plague Diseases 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 241000224017 Plasmodium berghei Species 0.000 description 1
• 241000223821 Plasmodium malariae Species 0.000 description 1
• 206010035501 Plasmodium malariae infection Diseases 0.000 description 1
• 206010035502 Plasmodium ovale infection Diseases 0.000 description 1
• 241000233872 Pneumocystis carinii Species 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 229920001214 Polysorbate 60 Polymers 0.000 description 1
• 206010036422 Postpartum sepsis Diseases 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 208000004210 Pressure Ulcer Diseases 0.000 description 1
• 241000283080 Proboscidea <mammal> Species 0.000 description 1
• 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 208000020264 Puerperal Infection Diseases 0.000 description 1
• 206010037575 Pustular psoriasis Diseases 0.000 description 1
• 206010037596 Pyelonephritis Diseases 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 208000033464 Reiter syndrome Diseases 0.000 description 1
• 241000725643 Respiratory syncytial virus Species 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 208000004364 Rhinosporidiosis Diseases 0.000 description 1
• 241000235527 Rhizopus Species 0.000 description 1
• 241000606701 Rickettsia Species 0.000 description 1
• 241000606695 Rickettsia rickettsii Species 0.000 description 1
• 206010039207 Rocky Mountain Spotted Fever Diseases 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 241000447727 Scabies Species 0.000 description 1
• 241000132889 Scedosporium Species 0.000 description 1
• 241000122799 Scopulariopsis Species 0.000 description 1
• 241000223255 Scytalidium Species 0.000 description 1
• 206010040070 Septic Shock Diseases 0.000 description 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
• 244000044822 Simmondsia californica Species 0.000 description 1
• 235000004433 Simmondsia californica Nutrition 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
• 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
• 206010041736 Sporotrichosis Diseases 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 241000191963 Staphylococcus epidermidis Species 0.000 description 1
• 241001147691 Staphylococcus saprophyticus Species 0.000 description 1
• 241001478878 Streptobacillus Species 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000193985 Streptococcus agalactiae Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 241000272534 Struthio camelus Species 0.000 description 1
• 241000271567 Struthioniformes Species 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 201000009594 Systemic Scleroderma Diseases 0.000 description 1
• 206010042953 Systemic sclerosis Diseases 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 239000003490 Thiodipropionic acid Substances 0.000 description 1
• 241000130764 Tinea Species 0.000 description 1
• 206010044248 Toxic shock syndrome Diseases 0.000 description 1
• 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
• 241000223997 Toxoplasma gondii Species 0.000 description 1
• 201000005485 Toxoplasmosis Diseases 0.000 description 1
• 241000224527 Trichomonas vaginalis Species 0.000 description 1
• 241000893963 Trichophyton concentricum Species 0.000 description 1
• 241001480046 Trichophyton schoenleinii Species 0.000 description 1
• 241000985906 Trichophyton soudanense Species 0.000 description 1
• 241001480050 Trichophyton violaceum Species 0.000 description 1
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
• 241001442399 Trypanosoma brucei gambiense Species 0.000 description 1
• 241001442397 Trypanosoma brucei rhodesiense Species 0.000 description 1
• 241000607626 Vibrio cholerae Species 0.000 description 1
• 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
• 206010047505 Visceral leishmaniasis Diseases 0.000 description 1
• FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
• 229930003270 Vitamin B Natural products 0.000 description 1
• 229930003316 Vitamin D Natural products 0.000 description 1
• QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
• 208000000260 Warts Diseases 0.000 description 1
• 241000710886 West Nile virus Species 0.000 description 1
• 238000007239 Wittig reaction Methods 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 206010061418 Zygomycosis Diseases 0.000 description 1
• IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
• WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
• OCRUMFQGIMSFJR-FSAWCSQFSA-N [(2s,3s,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-[(z)-octadec-9-enoyl]oxy-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl (z)-octadec-9-enoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCC\C=C/CCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC OCRUMFQGIMSFJR-FSAWCSQFSA-N 0.000 description 1
• SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
• HVUMOYIDDBPOLL-XGKPLOKHSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XGKPLOKHSA-N 0.000 description 1
• 241000222126 [Candida] glabrata Species 0.000 description 1
• WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• RRUDCFGSUDOHDG-UHFFFAOYSA-N acetohydroxamic acid Chemical compound CC(O)=NO RRUDCFGSUDOHDG-UHFFFAOYSA-N 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 201000007691 actinomycosis Diseases 0.000 description 1
• 239000011149 active material Substances 0.000 description 1
• 239000008186 active pharmaceutical agent Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 229940040563 agaric acid Drugs 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
• IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 150000001335 aliphatic alkanes Chemical class 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000003282 alkyl amino group Chemical group 0.000 description 1
• 125000004414 alkyl thio group Chemical group 0.000 description 1
• 125000005237 alkyleneamino group Chemical group 0.000 description 1
• 125000005238 alkylenediamino group Chemical group 0.000 description 1
• 125000005530 alkylenedioxy group Chemical group 0.000 description 1
• 125000005529 alkyleneoxy group Chemical group 0.000 description 1
• 125000000304 alkynyl group Chemical group 0.000 description 1
• RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
• 229960003942 amphotericin b Drugs 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 229940031955 anhydrous lanolin Drugs 0.000 description 1
• 239000000058 anti acne agent Substances 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 229940124599 anti-inflammatory drug Drugs 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 230000002725 anti-mycoplasma Effects 0.000 description 1
• 239000012296 anti-solvent Substances 0.000 description 1
• 238000002832 anti-viral assay Methods 0.000 description 1
• 229940124340 antiacne agent Drugs 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 238000009635 antibiotic susceptibility testing Methods 0.000 description 1
• 238000002827 antifungal susceptibility testing Methods 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 229940124434 antimycoplasmal agent Drugs 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 125000005165 aryl thioxy group Chemical group 0.000 description 1
• 229940091771 aspergillus fumigatus Drugs 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 208000009361 bacterial endocarditis Diseases 0.000 description 1
• 201000009904 bacterial meningitis Diseases 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
• 229940092714 benzenesulfonic acid Drugs 0.000 description 1
• 229960003872 benzethonium Drugs 0.000 description 1
• 125000005605 benzo group Chemical group 0.000 description 1
• 235000019400 benzoyl peroxide Nutrition 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• 150000001277 beta hydroxy acids Chemical class 0.000 description 1
• 235000013361 beverage Nutrition 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 238000002306 biochemical method Methods 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
• 229940036350 bisabolol Drugs 0.000 description 1
• HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• UYANAUSDHIFLFQ-UHFFFAOYSA-N borinic acid Chemical compound OB UYANAUSDHIFLFQ-UHFFFAOYSA-N 0.000 description 1
• 229910052794 bromium Inorganic materials 0.000 description 1
• 238000002815 broth microdilution Methods 0.000 description 1
• 229940056450 brucella abortus Drugs 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 208000000594 bullous pemphigoid Diseases 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 229960002962 butenafine Drugs 0.000 description 1
• ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 235000010376 calcium ascorbate Nutrition 0.000 description 1
• 239000011692 calcium ascorbate Substances 0.000 description 1
• 229940047036 calcium ascorbate Drugs 0.000 description 1
• 235000010216 calcium carbonate Nutrition 0.000 description 1
• BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
• 208000032343 candida glabrata infection Diseases 0.000 description 1
• 229940055022 candida parapsilosis Drugs 0.000 description 1
• 201000003984 candidiasis Diseases 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 150000001721 carbon Chemical group 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 239000001913 cellulose Chemical class 0.000 description 1
• 229920002678 cellulose Chemical class 0.000 description 1
• 235000010980 cellulose Nutrition 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 229940081733 cetearyl alcohol Drugs 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 229940038705 chlamydia trachomatis Drugs 0.000 description 1
• 229960003260 chlorhexidine Drugs 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 229960002242 chlorocresol Drugs 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 150000001841 cholesterols Chemical class 0.000 description 1
• 239000012459 cleaning agent Substances 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 229960004022 clotrimazole Drugs 0.000 description 1
• VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
• 239000011280 coal tar Substances 0.000 description 1
• 201000003486 coccidioidomycosis Diseases 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• 235000017471 coenzyme Q10 Nutrition 0.000 description 1
• ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
• 229940110767 coenzyme Q10 Drugs 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000007398 colorimetric assay Methods 0.000 description 1
• 230000000536 complexating effect Effects 0.000 description 1
• 229940125758 compound 15 Drugs 0.000 description 1
• 229940125898 compound 5 Drugs 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 239000007859 condensation product Substances 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 208000010247 contact dermatitis Diseases 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 238000005138 cryopreservation Methods 0.000 description 1
• 125000000392 cycloalkenyl group Chemical group 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
• 201000003146 cystitis Diseases 0.000 description 1
• 230000000120 cytopathologic effect Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 229960000860 dapsone Drugs 0.000 description 1
• DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical compound CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 210000004207 dermis Anatomy 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
• 238000002845 discoloration Methods 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 208000001848 dysentery Diseases 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 229960003913 econazole Drugs 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000008387 emulsifying waxe Substances 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 150000002084 enol ethers Chemical class 0.000 description 1
• 229940007078 entamoeba histolytica Drugs 0.000 description 1
• 229940032049 enterococcus faecalis Drugs 0.000 description 1
• 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
• 201000011114 epidermolysis bullosa acquisita Diseases 0.000 description 1
• 210000002409 epiglottis Anatomy 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 235000010350 erythorbic acid Nutrition 0.000 description 1
• 239000004318 erythorbic acid Substances 0.000 description 1
• YFXCNIVBAVFOBX-UHFFFAOYSA-N ethenylboronic acid Chemical compound OB(O)C=C YFXCNIVBAVFOBX-UHFFFAOYSA-N 0.000 description 1
• 239000012259 ether extract Substances 0.000 description 1
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 210000001508 eye Anatomy 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 210000004905 finger nail Anatomy 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 235000019253 formic acid Nutrition 0.000 description 1
• 239000003205 fragrance Substances 0.000 description 1
• 229940118764 francisella tularensis Drugs 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000003349 gelling agent Substances 0.000 description 1
• 229910052732 germanium Inorganic materials 0.000 description 1
• GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
• 201000006592 giardiasis Diseases 0.000 description 1
• 229940097043 glucuronic acid Drugs 0.000 description 1
• 229940074045 glyceryl distearate Drugs 0.000 description 1
• 239000004519 grease Substances 0.000 description 1
• 150000004795 grignard reagents Chemical class 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 229940091561 guaiac Drugs 0.000 description 1
• 229940047650 haemophilus influenzae Drugs 0.000 description 1
• 125000005843 halogen group Chemical group 0.000 description 1
• 239000007902 hard capsule Substances 0.000 description 1
• 229940037467 helicobacter pylori Drugs 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 231100000334 hepatotoxic Toxicity 0.000 description 1
• 230000003082 hepatotoxic effect Effects 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 125000004366 heterocycloalkenyl group Chemical group 0.000 description 1
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 229960000890 hydrocortisone Drugs 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• 229940071870 hydroiodic acid Drugs 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 229920001600 hydrophobic polymer Polymers 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
• 239000003701 inert diluent Substances 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 201000007119 infective endocarditis Diseases 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• ZCYVEMRRCGMTRW-YPZZEJLDSA-N iodine-125 Chemical compound [125I] ZCYVEMRRCGMTRW-YPZZEJLDSA-N 0.000 description 1
• 229940044173 iodine-125 Drugs 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• 239000002085 irritant Substances 0.000 description 1
• 229940026239 isoascorbic acid Drugs 0.000 description 1
• 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 229960004130 itraconazole Drugs 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• 230000003780 keratinization Effects 0.000 description 1
• 239000003410 keratolytic agent Substances 0.000 description 1
• 229960004125 ketoconazole Drugs 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 1
• 229960001627 lamivudine Drugs 0.000 description 1
• 229940039717 lanolin Drugs 0.000 description 1
• 235000019388 lanolin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 229940115932 legionella pneumophila Drugs 0.000 description 1
• 206010024428 lichen nitidus Diseases 0.000 description 1
• 201000011486 lichen planus Diseases 0.000 description 1
• 229960004194 lidocaine Drugs 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
• 235000019136 lipoic acid Nutrition 0.000 description 1
• 239000012669 liquid formulation Substances 0.000 description 1
• DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
• 239000003589 local anesthetic agent Substances 0.000 description 1
• 229960005015 local anesthetics Drugs 0.000 description 1
• 238000012153 long-term therapy Methods 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 229940067190 mentholatum Drugs 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 238000006263 metalation reaction Methods 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
• SJFNDMHZXCUXSA-UHFFFAOYSA-M methoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COC)C1=CC=CC=C1 SJFNDMHZXCUXSA-UHFFFAOYSA-M 0.000 description 1
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
• 229960002509 miconazole Drugs 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 230000002906 microbiologic effect Effects 0.000 description 1
• 210000001589 microsome Anatomy 0.000 description 1
• 208000020298 milker nodule Diseases 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 125000002950 monocyclic group Chemical group 0.000 description 1
• 125000006682 monohaloalkyl group Chemical group 0.000 description 1
• 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 1
• 235000011929 mousse Nutrition 0.000 description 1
• 201000000626 mucocutaneous leishmaniasis Diseases 0.000 description 1
• 201000007524 mucormycosis Diseases 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
• PHHRKRGXWSEXFZ-UHFFFAOYSA-N n-(pyridin-3-ylmethyl)-3-[[2-[(2,3,4-trifluorophenoxy)methyl]-1,3-benzoxazol-4-yl]oxy]propan-1-amine Chemical compound FC1=C(F)C(F)=CC=C1OCC(OC1=CC=C2)=NC1=C2OCCCNCC1=CC=CN=C1 PHHRKRGXWSEXFZ-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
• 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 229960003966 nicotinamide Drugs 0.000 description 1
• 235000005152 nicotinamide Nutrition 0.000 description 1
• 239000011570 nicotinamide Substances 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 125000002560 nitrile group Chemical group 0.000 description 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
• 231100000956 nontoxicity Toxicity 0.000 description 1
• 229960000988 nystatin Drugs 0.000 description 1
• VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
• 239000007764 o/w emulsion Substances 0.000 description 1
• 229960001679 octinoxate Drugs 0.000 description 1
• 239000012053 oil suspension Substances 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 239000003605 opacifier Substances 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 201000009838 otomycosis Diseases 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 125000004430 oxygen atom Chemical group O* 0.000 description 1
• 229960003540 oxyquinoline Drugs 0.000 description 1
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
• 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 206010034674 peritonitis Diseases 0.000 description 1
• 239000012466 permeate Substances 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 239000003209 petroleum derivative Substances 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• 229940100595 phenylacetaldehyde Drugs 0.000 description 1
• PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 125000003367 polycyclic group Chemical group 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 125000006684 polyhaloalkyl group Polymers 0.000 description 1
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
• 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
• 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 230000002250 progressing effect Effects 0.000 description 1
• 229940055019 propionibacterium acne Drugs 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 235000013772 propylene glycol Nutrition 0.000 description 1
• 229940093625 propylene glycol monostearate Drugs 0.000 description 1
• 125000006239 protecting group Chemical group 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
• 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 1
• 125000004076 pyridyl group Chemical group 0.000 description 1
• 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
• 229960002026 pyrithione Drugs 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
• MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 208000002574 reactive arthritis Diseases 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• 238000007430 reference method Methods 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 150000004492 retinoid derivatives Chemical class 0.000 description 1
• 229960003471 retinol Drugs 0.000 description 1
• 235000020944 retinol Nutrition 0.000 description 1
• 239000011607 retinol Substances 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 201000003068 rheumatic fever Diseases 0.000 description 1
• 208000007442 rickets Diseases 0.000 description 1
• 229940075118 rickettsia rickettsii Drugs 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 239000011435 rock Substances 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 229940081974 saccharin Drugs 0.000 description 1
• 235000019204 saccharin Nutrition 0.000 description 1
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
• 229930195734 saturated hydrocarbon Natural products 0.000 description 1
• 208000005687 scabies Diseases 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
• 229960005265 selenium sulfide Drugs 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 201000009890 sinusitis Diseases 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• 206010040872 skin infection Diseases 0.000 description 1
• 201000010153 skin papilloma Diseases 0.000 description 1
• 201000002612 sleeping sickness Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 235000010378 sodium ascorbate Nutrition 0.000 description 1
• PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
• 229960005055 sodium ascorbate Drugs 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 239000012453 solvate Substances 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
• 239000001570 sorbitan monopalmitate Substances 0.000 description 1
• 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
• 235000011076 sorbitan monostearate Nutrition 0.000 description 1
• 239000001587 sorbitan monostearate Substances 0.000 description 1
• 229940035048 sorbitan monostearate Drugs 0.000 description 1
• 235000011078 sorbitan tristearate Nutrition 0.000 description 1
• 239000001589 sorbitan tristearate Substances 0.000 description 1
• 229960004129 sorbitan tristearate Drugs 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 230000003595 spectral effect Effects 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 208000005801 spondylosis Diseases 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 238000005507 spraying Methods 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 229940098760 steareth-2 Drugs 0.000 description 1
• 229940100458 steareth-21 Drugs 0.000 description 1
• 229940012831 stearyl alcohol Drugs 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 229940030998 streptococcus agalactiae Drugs 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 238000005556 structure-activity relationship Methods 0.000 description 1
• 125000005504 styryl group Chemical group 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 229960002607 sulconazole Drugs 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 238000009121 systemic therapy Methods 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 229960002722 terbinafine Drugs 0.000 description 1
• DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
• 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
• ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
• 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• XAGUNWDMROKIFJ-UHFFFAOYSA-J tetrapotassium;2-[2-[[8-[bis(carboxylatomethyl)amino]-6-methoxyquinolin-2-yl]methoxy]-n-(carboxylatomethyl)-4-methylanilino]acetate Chemical compound [K+].[K+].[K+].[K+].C1=CC2=CC(OC)=CC(N(CC([O-])=O)CC([O-])=O)=C2N=C1COC1=CC(C)=CC=C1N(CC([O-])=O)CC([O-])=O XAGUNWDMROKIFJ-UHFFFAOYSA-J 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229940033663 thimerosal Drugs 0.000 description 1
• 229960002663 thioctic acid Drugs 0.000 description 1
• 235000019303 thiodipropionic acid Nutrition 0.000 description 1
• 235000010384 tocopherol Nutrition 0.000 description 1
• 229930003799 tocopherol Natural products 0.000 description 1
• 229960001295 tocopherol Drugs 0.000 description 1
• 239000011732 tocopherol Substances 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 239000003860 topical agent Substances 0.000 description 1
• 239000006208 topical dosage form Substances 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 206010044325 trachoma Diseases 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 229910052722 tritium Inorganic materials 0.000 description 1
• 229960004418 trolamine Drugs 0.000 description 1
• 229960000281 trometamol Drugs 0.000 description 1
• 201000008827 tuberculosis Diseases 0.000 description 1
• 206010061393 typhus Diseases 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 229940118696 vibrio cholerae Drugs 0.000 description 1
• 230000009447 viral pathogenesis Effects 0.000 description 1
• 235000019155 vitamin A Nutrition 0.000 description 1
• 239000011719 vitamin A Substances 0.000 description 1
• 235000019156 vitamin B Nutrition 0.000 description 1
• 239000011720 vitamin B Substances 0.000 description 1
• 150000003698 vitamin B derivatives Chemical class 0.000 description 1
• 235000019166 vitamin D Nutrition 0.000 description 1
• 239000011710 vitamin D Substances 0.000 description 1
• 150000003710 vitamin D derivatives Chemical class 0.000 description 1
• 229940045997 vitamin a Drugs 0.000 description 1
• 229940046008 vitamin d Drugs 0.000 description 1
• 150000003722 vitamin derivatives Chemical class 0.000 description 1
• 239000007762 w/o emulsion Substances 0.000 description 1
• 238000010792 warming Methods 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011787 zinc oxide Substances 0.000 description 1
• 229960001296 zinc oxide Drugs 0.000 description 1
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1